Abstract
The present study showed that platelet-activating factor (1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine, PAF), but not lysoPAF (1-O-hexadecyl-sn-glycero-3-phosphocholine) rapidly (within 15 sec) stimulated the incorporation of both [1-14C]arachidonate and [1-14C]docosahexaenoate into phosphatidylinositol (PI) and phosphatidylcholine (PC) in human neutrophils. Concomitantly, it inhibited the formation of labeled phosphatidic acid from both fatty acids. The magnitude of stimulation (percentage of control) was greater in PI than in PC for the incorporation of arachidonate and vice versa for the incorporation of docosahexaenoate. It reached a maximum at 10−7 M and started to decline at 10−6 M. Extracellular Ca2+ was not essential for the action of PAF on phospholipid acylation. The distribution of labeled arachidonate in the molecular species of PC was not altered by PAF after 1 min incubation, suggesting that the increased formation of arachidonyl-PC during the early stage of neutrophil-PAF interaction was not originated from the added PAF. No measurable changes in the mass of each phospholipid were detected in neutrophils challenged by PAF from 15 sec to 2 min. The data suggest that the increased incorporated of extracellular fatty acids into PI and PC elicited by PAF may be secondary to increased deacylation of these phospholipids, and the magnitude of stimulation reflects the specificity of acyltransferase catalyzing the acylation of lysoPI and lysoPC by fatty acyl-CoA.
Similar content being viewed by others
References
Ohlrogge, J.B. (1982)Trends Biochem. Sci. 7, 235.
Snyder, F. (1982)Ann. Rep. Med. Chem. 17, 242–251.
Vargaftig, B.B., and Benveniste, J. (1983)Trends Pharm. Sci. 4, 341–343.
Hanahan, D.J. (1986)Ann. Rev. Biochem. 55, 483–509.
Shaw, J.O., Pinckard, R.N., Ferrigni, K.S., McManus, L.M., and Hanahan, D.J. (1981)J. Immunol. 127, 1250–1255.
Ingraham, L.M., Coates, T.D., Allen, J.M., Higgens, C.P., Baehner, R.L., and Boxer, L.A. (1982)Blood 59, 1259–1266.
Gay, J.C., Beckman, J.K., Zaboy, K.A., and Lukens, J.N. (1986)Blood 67, 931–936.
Naccache, P.H., Molski, M.M., Volpi, M., Shefcyk, J., Molski, T.F.P., Loew, L., Becker, E.L., and Sha'afi, R.I. (1986)J. Leukocyte Biol. 40, 533–548.
Chilton, R.H., O'Flaherty, J.T., Walsh, C.E., Thomas, M.J., Wykle, R.L., DeChatelet, L.R., and Waite, B.M. (1982)J. Biol. Chem. 257, 5402–5407.
Tou, J.-S. (1985)Biochem. Biophys. Res. Commun. 127, 1045–1051.
Takamori, K., and Yamashita, T. (1980)Infec. Immun. 29, 353–400.
Pember, S.O., Barnes, K.C., Brandt, S.J., and Kindade, J.M. Jr. (1983)Blood 61, 1105–1115.
Tou, J.-S. (1984)Lipids 19, 573–577.
Tou, J.-S. (1986)Lipids 21, 324–327.
Lee, T.H., Mencia-Huerta, J.-M., Shih, C., Corey, E.J., Lewis, R.A., and Austen, K.F. (1984)J. Clin. Invest. 74, 1922–1933.
Tou, J.-S., and Stjernholm, R.L. (1975)Biochim. Biophys. Acta 392, 1–11.
Bligh, E.C., and Dyer, W.J. (1959)Can. J. Biochem. Physiol. 37, 911–917.
Lee, T.-C., Malone, B., Blank, M.L., and Snyder, F. (1981)Biochem. Biophys. Res. Commun. 102, 1262–1268.
Smith, R.J., Bowman, B.J., and Iden, S.S. (1984)Biochem. Pharmacol. 33, 973–978.
Rubin, R.P., Sink, L.E., Schrey, M.P., Day, A.R., Liao, C.S., and Freer, R.J. (1979)Biochem. Biophys. Res. Commun. 90, 1364–1370.
Tou, J.-S. (1981)Biochim. Biophys. Acta 655, 491–497.
Bazan, H.E.P., Sprecher, H., and Bazan, N.G. (1984)Biochim. Biophys. Acta 796, 11–19.
Billah, M.M., Bryant, R.W., and Siegel, M.I. (1985)J. Biol. Chem. 260, 6899–6906.
Chilton, F.H., and Murphy, R.C. (1986)J. Biol. Chem. 261, 7771–7777.
Sugiura, T., Onuma, Y., Sekiguchi, N., and Waku, K. (1982)Biochim. Biophys. Acta 712, 515–522.
Ban, C., Billah, M., Truong, C.T., and Johnston, J.M. (1986)Arch. Biochem. Biophys. 246, 9–18.
Märki, F., and Franson, R. (1986)Biochim. Biophys. Acta 879, 149–156.
Chilton, F.H., O'Flaherty, J.T., Ellis, J.M., Swendsen, C.L., and Wykle, R.L. (1983)J. Biol. Chem. 258, 7268–7271.
Chilton, F.H., O'Flaherty, J.T., Ellis, J.M., Swendsen, C.L., and Wykle, R.L. (1983)J. Biol. Chem. 258, 6357–6361.
Malone, B., Lee, T.-C., and Snyder, F. (1985)J. Biol. Chem. 260, 1531–1534.
Touqui, L., Jacquemin, C., Dumarey, C., and Vargaftig, B.B. (1985)Biochim. Biophys. Acta 833, 111–118.
Chilton, F.H., Hadley, J.S., and Murphy, R.C. (1987)Biochim. Biophys. Acta 917, 48–56.
Elsbach, P. (1968)J. Clin. Invest. 47, 2217–2229.
Shohet, S.B. (1970)J. Lab. Clin. Med. 75, 659–672.
Palmlad, J., Malmsten, C.L., Uden, A.-M., Radmark, O., Engstedt, L., and Samuelson, B. (1981)Blood 58, 658–661.
Klicksteim, L.B., Shapleigh, C., and Goetzl, E.J. (1980)J. Clin. Invest. 66, 1166–1170.
Author information
Authors and Affiliations
About this article
Cite this article
Tou, Js. Platelet-activating factor modulates phospholipid acylation in human neutrophils. Lipids 22, 333–337 (1987). https://doi.org/10.1007/BF02534002
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02534002